J. Sakurai

Randomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301)

Y. Tajima, J. Sakamoto, S. Tatebe, 2011, Anti-cancer drugs.

Carboplatin plus Weekly Paclitaxel Combined with Bevacizumab as First-line Treatment for Non-small Cell Lung Cancer.

N. Hattori, M. Yamasaki, T. Kondo, 2017, Anticancer research.

Randomized phase II trial of first-line treatment with tailored irinotecan plus S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301) Running head: Tailored IRIS vs. S-1 as first-line therapy for gastric cancer

Y. Tajima, J. Sakamoto, S. Tatebe, 2017 .